Molecular MS Diagnostics, also known as MMSD, is an analytical and bioanalytical contract laboratory supporting pharmaceutical, biotech, and research organizations with method development, product testing, stability work, impurity analysis, LC-MS/MS bioanalysis, and strategic product development services. The company is based in Warwick, Rhode Island and supports R&D analytical, GMP analytical, and bioanalytical testing needs.

Overview

MMSD is built for sponsors that need a specialized analytical lab without the overhead of building or maintaining those capabilities internally. Their team supports drug development programs with analytical testing, bioanalytical method development, product characterization, release testing, impurity identification, and stability-related services.

For biotech, pharma, and formulation teams working on small molecules, peptides, proteins, medical device excipients, or early product development programs, MMSD offers a practical outsourcing option for analytical and bioanalytical work that requires speed, method flexibility, and experienced technical support.

Accreditations & Compliance

MMSD supports R&D analytical and GMP analytical product testing. Public materials state that the company is ISO 9001:2015 certified, DEA registered for Schedule II–V substances, FDA registered, and operates with SOPs, sample management, QA-reviewed data, equipment IQ/OQ/PQ documentation, and automated temperature and humidity monitoring for freezers, refrigerators, and stability chambers.

For regulated studies, sponsors should confirm project-specific requirements before launch, including GLP status, GMP release expectations, method validation needs, QA review, raw data access, reporting format, and intended regulatory use.

Core Services

MMSD provides analytical services across drug assay and impurity method development, R&D analytical support, CMC analytical support, cGMP release testing, excipient analysis, content uniformity testing, forced degradation studies, extractables and leachables testing, photostability testing, dissolution testing, residual solvent analysis, impurity identification, stability testing, chiral analysis, and counterfeit drug analysis.

Their bioanalytical services include plasma and urine analysis of small-molecule drugs, peptides, and proteins; rapid-turnaround pharmacokinetic sample analysis; GLP and non-GLP method development and validation; metabolite identification; plasma and blood stability assays; plasma protein binding screens; HPLC purification; GC headspace analysis; ADME profiling; PK analysis; P450 screens; hepatocyte induction assays; and tissue analysis.

Technology & Expertise

MMSD’s platform is centered on analytical chemistry, bioanalysis, chromatography, and mass spectrometry. Their equipment includes HPLC systems, GC-FID, dissolution equipment, HPLC-MS/MS, UPLC FL/PDA/MS, ICP-MS for heavy metals analysis, GC-MS, Karl Fischer testing, TOC, and DSC.

Their capabilities are especially useful for sponsors that need LC-MS/MS method development, method verification, method validation, method transfer, plasma or blood stability assays, plasma and urine analysis, pre-formulation support, stability testing, photostability testing, de-formulation, and early feasibility work.

Best Fit Projects

MMSD is a strong fit for projects involving analytical method development, LC-MS/MS bioanalysis, impurity identification, extractables and leachables, residual solvents, stability testing, photostability, dissolution, drug release testing, plasma or urine PK sample analysis, small-molecule bioanalysis, peptide and protein analysis, ADME support, product characterization, and GMP analytical testing.

They are especially well suited for sponsors that need a specialized analytical partner for development-stage testing, product troubleshooting, method transfer, or bioanalytical support without engaging a larger full-service CRO.

Why Work With Molecular MS Diagnostics Through CROaccess

Through CROaccess, sponsors can evaluate MMSD for analytical, bioanalytical, LC-MS/MS, stability, CMC, and product development testing needs while comparing fit against other qualified CROs and specialty laboratories.

MMSD brings focused analytical and bioanalytical laboratory expertise, while CROaccess helps sponsors manage vendor evaluation, proposal collection, documentation, communication, and project tracking in one centralized platform.